Table 12.14b

Unadjusted Patient Survival, Living Donor Lung Transplants

Survival at 3 Months, 1 Year, 3 Years, and 5 Years

		3 Months			1 Year			3 Years			5 Years
		(Tx 2003 - 2004)			(Tx 2003 - 2004)			(Tx 2001 - 2004)			(Tx 1999 - 2004)
		N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.
Total	All	28	89.3%	5.8%	28	89.3%	5.8%	61	73.6%	6.0%	104	56.5%	5.8%
Primary Diagnosis	Cystic Fibrosis	23	91.3%	5.9%	23	91.3%	5.9%	49	71.1%	6.9%	89	51.6%	6.3%
	Idiopathic Pulmonary Fibrosis	2	100.0%	0.0%	2	100.0%	0.0%	6	83.3%	15.2%	6	+	+
	Primary Pulmonary Hypertension	0	-	-	0	-	-	2	100.0%	0.0%	2	+	+
	Congenital Disease	0	-	-	0	-	-	0	-	-	0	-	-
	Other	3	66.7%	27.2%	3	66.7%	27.2%	4	75.0%	21.7%	7	85.7%	13.2%

Source: OPTN/SRTR Data as of May 1, 2006.

(+) = Values not determined due to insufficient follow-up. (-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Patient survival follows patients from first transplant of this type until death. Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on lung and heart-lung transplants.

Multi-organ transplants are excluded.